Skip to content
drillr.ai
Sign up

DTIL

PRECISION BIOSCIENCES INC

NASDAQ · Healthcare · Biotechnology · US

$6.67
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-6.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 5, 2026Pire Shari Lisa · directorA-Award20,979$0.00
Jun 5, 2026Frankel Stanley · directorA-Award20,979$0.00
Jun 5, 2026Brown Melinda · directorA-Award20,979$0.00
Jun 5, 2026Buehler Kevin · directorA-Award20,979$0.00
Jun 5, 2026Germano Geno J · directorA-Award20,979$0.00
May 22, 2026Brown Melinda · directorM-Exempt21,000$0.00
May 22, 2026Frankel Stanley · directorM-Exempt21,000$0.00
May 22, 2026Buehler Kevin · directorM-Exempt21,000$0.00
May 22, 2026Germano Geno J · directorM-Exempt21,000$0.00
May 22, 2026Pire Shari Lisa · directorM-Exempt21,000$0.00
Feb 19, 2026Scimeca Dario · officer: General Counsel and SecretarySale4,925$3.84
Feb 19, 2026Kelly John Alexander · officer: Chief Financial OfficerSale8,149$3.84
Feb 19, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt27,584$0.00
Feb 19, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt16,667$0.00
Feb 19, 2026Amoroso Michael · director, officer: President and CEOM-Exempt67,797$0.00
Feb 19, 2026Amoroso Michael · director, officer: President and CEOSale20,559$3.84
Feb 19, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerSale4,925$3.84
Feb 19, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerM-Exempt16,667$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerSale15,213$4.03
Jan 22, 2026Amoroso Michael · director, officer: President and CEOM-Exempt37,069$0.00
Jan 22, 2026Amoroso Michael · director, officer: President and CEOM-Exempt8,888$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt14,908$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretarySale8,854$4.03
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt8,425$0.00
Jan 22, 2026Scimeca Dario · officer: General Counsel and SecretaryM-Exempt1,978$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt26,575$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt13,900$0.00
Jan 22, 2026Kelly John Alexander · officer: Chief Financial OfficerM-Exempt3,888$0.00
Jan 22, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerM-Exempt16,219$0.00
Jan 22, 2026SMITH J. JEFFERSON · officer: Chief Research OfficerSale10,200$4.03
Institutional positioning

13F filings over the trailing two quarters

New 52Increased 55Reduced 29Sold out 12
FilerActionSharesFiled
OCTAGON CAPITAL ADVISORS LPIncreased2,236,732May 15, 2026
Aberdeen Group plcUnchanged2,230,178Jul 31, 2026
ABRDN PLCIncreased2,230,178Apr 29, 2026
Bleichroeder LPIncreased2,018,190Aug 13, 2026
EMPERY ASSET MANAGEMENT, LPReduced1,968,879May 8, 2026
BLEICHROEDER LPUnchanged1,662,500May 14, 2026
Octagon Capital Advisors LPReduced1,350,000Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCIncreased1,346,004Aug 14, 2026
BlackRock, Inc.Increased1,172,873Aug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,116,241Aug 13, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged1,066,050May 15, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased995,371May 15, 2026
LYNX1 CAPITAL MANAGEMENT LPReduced985,113May 4, 2026
Lynx1 Capital Management LPReduced950,466Aug 13, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCReduced946,707Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 5, 2026